🇺🇸 FDA
Patent

US 11957684

Treatment of heavy menstrual bleeding associated with uterine fibroids

granted A61KA61K31/513A61K31/519

Quick answer

US patent 11957684 (Treatment of heavy menstrual bleeding associated with uterine fibroids) held by Takeda Pharmaceutical Company Limited expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/513, A61K31/519, A61K31/565, A61K31/57